Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Fibrosis × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 49 Carcinoma, Renal Cell 44 Neoplasm Metastasis 21 Neoplasms 17 Kidney Neoplasms 16 Neuroendocrine Tumors 14 Lymphoma, Mantle-Cell 12 Carcinoma, Non-Small-Cell Lung 11 Recurrence 10 Prostatic Neoplasms 10 Hodgkin Disease 10 Tuberous Sclerosis 9 Stomach Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma 9 Glioblastoma 9 Colorectal Neoplasms 9 Brain Neoplasms 9 Lymphoma, Follicular 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Carcinoma 8 Waldenstrom Macroglobulinemia 7 Triple Negative Breast Neoplasms 7 Sarcoma 7 Multiple Myeloma 7 Lymphoma, B-Cell, Marginal Zone 7 Glioma 7 Central Nervous System Neoplasms 7 Carcinoma, Neuroendocrine 7

Interventions

Tenofovir 2 Sorafenib 2 Low-Level Light Therapy 2 High-Energy Shock Waves 2 sonidegib 1 ruxolitinib 1 navitoclax 1 hepatitis B hyperimmune globulin 1 bavituximab 1 adefovir dipivoxil 1 Viusid 1 Vitamin E 1 Restraint, Physical 1 Physical Therapy Modalities 1 Pentoxifylline 1 Magnetic Resonance Spectroscopy 1 Liver Transplantation 1 Lamivudine 1 Independent Medical Evaluation 1 Everolimus 1 Erlotinib Hydrochloride 1 Enkephalin, Methionine 1 Dietary Supplements 1 Clinical Trials as Topic 1 Blood Specimen Collection 1 Angptl4 protein, mouse 1 ARQ 197 1 4-((5-chloro-2-pyridinyl)oxy)-1-((((4S)-4-methyl-2,5-dioxo-4-imidazolidinyl)methyl)sulfonyl)-piperidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02134899 2018-12-10

EVERKYSTE

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Cysts, Fibrosis, Polycystic Kidney, Autosomal Dominant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡